Skip Navigation LinksHome > September 2011 - Volume 111 - Issue 9 > New Drug for Type 2 Diabetes
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000405054.38571.4f
Drug Watch

New Drug for Type 2 Diabetes

Aschenbrenner, Diane S. MS, RN

Collapse Box

Abstract

* Linagliptin (Tradjenta) is the newest drug approved for type 2 diabetes.

* Linagliptin promotes the function of endogenous incretins, hormones that work to lower elevated blood glucose levels.

* The drug doesn't usually cause hypoglycemia and is generally well tolerated.

© 2011 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics